Clinical Trial Update: Evaluating Suzetrigine for Pain Control Following TKA [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating Suzetrigine for pain control after total knee arthroplasty and is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis
• Postoperative Pain

Drugs mentioned

• Suzetrigine (Suzetrigine)

Snippet

Sponsor: AdventHealth | Conditions: Postoperative Pain Following Knee Arthroplasty | Phase 3 | Status: NOT_YET_RECRUITING